Evidence map›Paper›PMID 9315626›Full record

ArticleMolecular and cellular biology1997

Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins.

C P Chang, Y Jacobs, T Nakamura, N A Jenkins, N G Copeland, M L Cleary

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 256 citations in OpenAlex.

  1. Article
  2. TALE and Hox Transcription Factors Control Adult Behaviors in Zebrafish.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Mechanistic insights into cardiac regeneration and protection through MEIS inhibition.Turkish journal of biology = Turk biyoloji dergisi · 2024
    Article
  7. BREVIPEDICELLUS Positively Regulates Salt-Stress Tolerance inInternational journal of molecular sciences · 2023
    Article
  8. Transcription factors in microcephaly.Frontiers in neuroscience · 2023
    Review
  9. Research progress of PBX1 in developmental and regenerative medicine.International journal of medical sciences · 2023
    Review
  10. Article
  11. Review
  12. MEIS1 and its potential as a cancer therapeutic target (Review).International journal of molecular medicine · 2021
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Oncogenic and tumor suppressor function of MEIS and associated factors.Turkish journal of biology = Turk biyoloji dergisi · 2020
    Article
  18. Article
  19. Article
  20. Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

C P ChangDepartment of Pathology, Stanford University Medical Center, California 94305, USA.
Y Jacobs
T Nakamura
N A Jenkins
N G Copeland
M L Cleary
Cancer Research Center · USStanford Medicine · US

Funding

TUMOR BIOLOGYT32CA009151 · NCI · STANFORD UNIVERSITY · PI CLEARY, MICHAEL L · 1985 to 2014
$5.5M
MOLECULAR PATHOLOGY OF LYMPHOID MALIGNANCIESR37CA042971 · NCI · STANFORD UNIVERSITY · PI CLEARY, MICHAEL L · 1999 to 2006
$3.6M
MOLECULAR PATHOLOGY OF LYMPHOID MALIGNANCIESR01CA042971 · NCI · STANFORD UNIVERSITY · PI CLEARY, MICHAEL L · 1986 to 1998
–
NCI NIH HHS CA09151NCI NIH HHS CA42971
6 · The paper itself

Abstract

The Pbx1 and Meis1 proto-oncogenes code for divergent homeodomain proteins that are targets for oncogenic mutations in human and murine leukemias, respectively, and implicated by genetic analyses to functionally collaborate with Hox proteins during embryonic development and/or oncogenesis. Although Pbx proteins have been shown to dimerize with Hox proteins and modulate their DNA binding properties in vitro, the biochemical compositions of endogenous Pbx-containing complexes have not been determined. In the present study, we demonstrate that Pbx and Meis proteins form abundant complexes that comprise a major Pbx-containing DNA binding activity in nuclear extracts of cultured cells and mouse embryos. Pbx1 and Meis1 dimerize in solution and cooperatively bind bipartite DNA sequences consisting of directly adjacent Pbx and Meis half sites. Pbx1-Meis1 heterodimers display distinctive DNA binding specificities and cross-bind to a subset of Pbx-Hox sites, including those previously implicated as response elements for the execution of Pbx-dependent Hox programs in vivo. Chimeric oncoprotein E2a-Pbx1 is unable to bind DNA with Meis1, due to the deletion of amino-terminal Pbx1 sequences following fusion with E2a. We conclude that Meis proteins are preferred in vivo DNA binding partners for wild-type Pbx1, a relationship that is circumvented by its oncogenic counterpart E2a-Pbx1.

Indexed as

Adenovirus E2 ProteinsAnimalsBinding SitesCell ExtractsCell NucleusCells, CulturedDimerizationDNADNA-Binding ProteinsHomeodomain ProteinsHumansMiceMyeloid Ecotropic Viral Integration Site 1 ProteinNeoplasm ProteinsOligodeoxyribonucleotidesPre-B-Cell Leukemia Transcription Factor 1Adenovirus E2 ProteinsCell ExtractsDNADNA-Binding ProteinsHomeodomain ProteinsMEIS1 protein, humanMeis1 protein, mouseMyeloid Ecotropic Viral Integration Site 1 ProteinNeoplasm ProteinsOligodeoxyribonucleotidesPBX1 protein, humanPre-B-Cell Leukemia Transcription Factor 1Proto-Oncogene ProteinsRecombinant Fusion Proteins

Identifiers

PMID9315626
PMCPMC232416
OpenAlexW2141034679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.